Here's Become Trillion Company: AMD Could Hit $1T Soon
AMD's growth story is gaining steam as data centers, AI workloads, and CPU/GPU innovations align. This guide breaks d...
Stock Market
This page features valuable insights into the Stock Market, covering topics like tariffs and dividend investing. Stay informed to enhance your investment strategies.
2,620 articles
Here's Blue Origin Rocket Could Fuel SpaceX IPO Comeback
The space-launch landscape is shifting as Blue Origin faces a setback. This could paradoxically amplify SpaceX's IPO ...
Applied Digital Stock Skyrocketed: What Fueled the Rally
A dramatic May rally sent applied digital stock skyrocketed as AI optimism surged. This piece breaks down the drivers...
Does President Trump’s Bull Market Start Up Again on Wednesday?
As inflation data looms and policy bets swirl, investors ask whether does president trump’s bull market start up agai...
NVIDIA Stock Will Trade at Higher Levels in 2027 Outlook
A growing chorus of analysts says the AI boom could lift nvidia stock will trade into the higher end of its range by ...
Synopsys Stock Could Reach $600 by March 2027, Analysts Say
Analysts are weighing a path for synopsys stock $600 march targets as AI-driven chip design demand grows, even as deb...
These Underperforming Dow Stocks Have Common Traits
Three Dow components lag this year, sharing three pressure points that investors still see as catalysts. Wall Street ...
Micron Rockets Western Digital as Memory Stocks Bounce Back
Micron Technology leads a Monday rebound in memory stocks, with Western Digital and SanDisk climbing as traders start...
Monday Reads: 10 Must-Read Investing Pieces for the Week
Start your week with anticipation and a sharper nose for risk. These monday reads pull back the curtain on real estat...
Why Micron Technology Stock Skyrocketed 87% Last Month
Micron ralled dramatically in May as memory chips rode AI and data-center demand. This deep dive explains what fueled...
Lilly Stock Jumps After Phase 3 Weight-Drug Readout
Lilly stock jumps after Phase 3 readout for a next-generation weight-loss drug exceeded expectations. Investors see d...
Zealand Pharma Loses Fifth of Value After Trial Dropouts
Danish biotech Zealand Pharma saw its stock slide after disclosing a 20% dropout rate in its weight-loss drug trial d...